|The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench|
MC Bacon, V Von Wyl, C Alden, G Sharp, E Robison, N Hessol, S Gange, ...
Clinical and diagnostic laboratory immunology 12 (9), 1013-1019, 2005
|Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a …|
L Wittkop, HF Günthard, F De Wolf, D Dunn, A Cozzi-Lepri, A De Luca, ...
The Lancet infectious diseases 11 (5), 363-371, 2011
|Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and …|
RK Gupta, A Hill, AW Sawyer, A Cozzi-Lepri, V von Wyl, S Yerly, VD Lima, ...
The Lancet infectious diseases 9 (7), 409-417, 2009
|Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries|
Antiretroviral Therapy Cohort Collaboration
International journal of epidemiology 38 (6), 1624-1633, 2009
|Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey|
S Yerly, V von Wyl, B Ledergerber, J Böni, J Schüpbach, P Bürgisser, ...
Aids 21 (16), 2223-2229, 2007
|Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland|
RD Kouyos, V Von Wyl, S Yerly, J Böni, P Taffé, C Shah, P Börgisser, ...
The Journal of infectious diseases 201 (10), 1488-1497, 2010
|Estimating the basic reproductive number from viral sequence data|
T Stadler, R Kouyos, V von Wyl, S Yerly, J Böni, P Bürgisser, T Klimkait, ...
Molecular biology and evolution 29 (1), 347-357, 2012
|Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types|
V Von Wyl, S Yerly, J Böni, P Bürgisser, T Klimkait, M Battegay, H Furrer, ...
Archives of internal medicine 167 (16), 1782-1790, 2007
|Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection|
RD Kouyos, V von Wyl, S Yerly, J Böni, P Rieder, B Joos, P Taffé, C Shah, ...
Clinical infectious diseases 52 (4), 532-539, 2011
|Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load|
S Alizon, V von Wyl, T Stadler, RD Kouyos, S Yerly, B Hirschel, J Böni, ...
PLoS Pathog 6 (9), e1001123, 2010
|The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infection|
S Yerly, T Junier, A Gayet-Ageron, EB El Amari, V von Wyl, HF Günthard, ...
Aids 23 (11), 1415-1423, 2009
|Complement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infection|
M Huber, M Fischer, B Misselwitz, A Manrique, H Kuster, B Niederöst, ...
PLoS Med 3 (11), e441, 2006
|Profound depletion of HIV-1 transcription in patients initiating antiretroviral therapy during acute infection|
A Schmid, S Gianella, V von Wyl, KJ Metzner, AU Scherrer, B Niederöst, ...
PloS one 5 (10), e13310, 2010
|Inferring epidemic contact structure from phylogenetic trees|
GE Leventhal, R Kouyos, T Stadler, V Von Wyl, S Yerly, J Böni, C Cellerai, ...
PLoS Comput Biol 8 (3), e1002413, 2012
|Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study|
SM Drescher, V von Wyl, WL Yang, J Böni, S Yerly, C Shah, V Aubert, ...
Clinical infectious diseases 58 (2), 285-294, 2014
|Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA|
S Gianella, V von Wyl, M Fischer, B Niederoest, M Battegay, E Bernasconi, ...
Antiviral therapy 16 (4), 535, 2011
|HIV-1 transmission after cessation of early antiretroviral therapy among men having sex with men|
P Rieder, B Joos, V von Wyl, H Kuster, C Grube, C Leemann, J Böni, ...
Aids 24 (8), 1177-1183, 2010
|The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland|
V von Wyl, RD Kouyos, S Yerly, J Böni, C Shah, P Bürgisser, T Klimkait, ...
Journal of infectious diseases 204 (7), 1095-1103, 2011
|Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment–experienced patients in Switzerland|
V von Wyl, S Yerly, J Böni, P Bürgisser, T Klimkait, M Battegay, ...
Clinical infectious diseases 48 (7), 979-987, 2009
|Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B|
AU Scherrer, B Ledergerber, V von Wyl, J Böni, S Yerly, T Klimkait, ...
Clinical infectious diseases 53 (11), 1143-1152, 2011